MediFind
LoginSign Up
Are we missing a condition or feature you’d like to see? MediFind is always evolving and we’d love your feedback.
MediFind
Condition

Non-Alcoholic Fatty Liver Disease

Active Clinical Trials

Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 260
  • Start Date: September 30, 2020
A Phase II, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Patients With Non-Alcoholic Steatohepatitis
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 5
  • Start Date: September 2020
Anaplerotic Therapy Using Triheptanoin for Patients With Glycogen Storage Disease Type I
Clinical Trial
Other
  • Status: Recruiting
  • Participants: 600
  • Start Date: August 14, 2020
Screening of NASH in Oupatients Followed in Various Hospital Specialty Clinics at the University Hospital of Strasbourg
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 180
  • Start Date: August 11, 2020
PHASE 2A, 2-PART, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY PLACEBO-CONTROLLED, PARALLEL-GROUP (SPONSOR OPEN) STUDY TO ASSESS PHARMACODYNAMICS AND SAFETY OF PF-06865571 (DGAT2I) COADMINISTERED WITH PF-05221304 (ACCI) IN ADULT PARTICIPANTS WITH PRESUMED NONALCOHOLIC STEATOHEPATITIS (NASH)
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 96
  • Start Date: August 10, 2020
A Phase I, Single-Center, Randomized, Double-Blind, Placebo-Controlled, Single- and Multiple-Ascending Dose Clinical Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HEC96719 Tablets in Healthy Subjects
Clinical Trial
Other
  • Status: Recruiting
  • Study Type: Other
  • Participants: 600
  • Start Date: August 7, 2020
Study for the Identification of Participants With Liver Steatosis Who Carry Genetic Variants Associated With Nonalcoholic Fatty Liver Disease (NAFLD)
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 112
  • Start Date: July 29, 2020
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate Efficacy, Safety and Tolerability of HM15211 Treatment for 12 Months in Subjects With Biopsy Confirmed NASH
Clinical Trial
Diagnostic Test
  • Status: Recruiting
  • Study Type: Diagnostic Test
  • Participants: 173
  • Start Date: July 3, 2020
The Diagnostic Performance Assessment of Quantitative Ultrasound Imaging Indices for Differentiating Hepatic Steatosis Grade in Patients With Non-alcoholic Fatty Liver Disease
Clinical Trial
Other
  • Status: Recruiting
  • Study Type: Other
  • Participants: 40
  • Start Date: July 2020
Safety and Efficacy of Ketogenic Diet for Promoting Weight Loss in Obese Individuals With Compensated NASH Cirrhosis
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 36
  • Start Date: June 23, 2020
A Multi-center, Randomized, Double-blind, Dose-increasing, Placebo-controlled，Multi-dose, 28-day Continuous Administration Phase Ib/IIa Clinical Trial to Evaluate the Tolerability, Efficacy, and PK of ZSP1601 in Patients With Nonalcoholic Steatohepatitis
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 1010
  • Start Date: June 22, 2020
A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 96
  • Start Date: June 18, 2020
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2a Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of Orally Administered TERN-101 Tablets in Adult Patients With Presumed Non-Cirrhotic Non-Alcoholic Steatohepatitis (NASH)
Showing 1–12 of 297 Clinical Trials
Next